About Us
Mission Statement
Our Committment to You

NABU Medical Services:

  • Provides comfortable, complete and confidential state-of-the-art detoxification from all substances of abuse.

  • Knows that addiction is a treatable disease.

  • Knows that people with this disease can detoxify safely and stay healthy, clean and sober.

  • Treats each patient with dignity and respect.

  • Provides personalized care to each patient: Each patient has Dr. Nathan's pager number and he is available to talk with the patient and thier family from 8AM-8PM (eastern time) daily.  Dr. Nathan is a pioneer in detoxification treatments such as Suboxone and Buprenorphine.
 


//A New Way to Detox//
What's new? Our approach to recovery!

  • Due to advances in detoxification methods such as Suboxone and Buprenorphine, we provide outpatient detoxifcation to many of those that thought they would have to go in-patient for detoxification.

  • Our services are transparent to our patients' employment. In most cases the patient can continue working during detoxification.

  • We provide the newest way to detoxify comfortably and completely from opiates. Our medical director is  ASAM certified in addiction medicine and is licensed to prescribe buprenorphine (Suboxone & Subutex) for outpatient opiate detoxification.
  • The NABU Method allows you to rapidly return to work with no downtime. In addition, you will be able to sleep and be without withdrawal symptoms from day one.
  • We provide referrals to addiction treatment experienced psychiatrists, psychologists, psychotherapists, acupuncturists and yoga instructors to help your body and mind get and stay healthy.


Dr. Nathan on CBS/The Early Show
Subject: Addicted To Pain Killers?

Dr. Joel Nathan on the CBS Early Show

CBS/The Early Show invited our very own, Dr. Joel Nathan, to provide details about the dangerous addiction to Oxycontin that not only impacts Rush Limbaugh, a famous radio personality, but more than 1.9 million other Americans, as well.

(Photo: CBS/The Early Show)

CBS Click here to see the interview